Cardiovascular Effects of Drugs Used to Treat Alzheimer's Disease

被引:85
|
作者
Howes, Laurence Guy [1 ]
机构
[1] Griffith Univ, Sch Med, Gold Coast Univ Hosp, Dept Cardiol, Southport, Qld 2015, Australia
关键词
CHOLINESTERASE-INHIBITORS; CHANNEL BLOCKERS; ELDERLY-PATIENTS; QT INTERVAL; DONEPEZIL; SYNCOPE; MEMANTINE; DEMENTIA; SAFETY; BRADYCARDIA;
D O I
10.1007/s40264-014-0161-z
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Drugs that are used to treat Alzheimer's disease include the acetyl cholinesterase inhibitors (ACHIs) donepezil, rivastigmine and galantamine and the NMDA receptor antagonist memantine. Adverse cardiovascular events with these drugs are very uncommon. However, there is evidence that ACHI therapy is associated with a small but significant increase in the risk of syncope and bradycardia. There are also a few reports that these drugs may occasionally be associated with QT prolongation and torsades de pointes ventricular tachycardia. Adverse cardiovascular effects of ACHIs including syncope and bradycardia are less common than their adverse gastrointestinal effects, but they remain important considerations in susceptible individuals. In contrast, animal studies and some observational studies suggest that ACHIs may reduce myocardial infarction and cardiovascular mortality and have favourable effects on hemodynamics and survival in heart failure. Further research is required to confirm these potential beneficial effects. Little is known about the cardiovascular effects of memantine but there have been reports of bradycardia and reduced cardiovascular survival associated with its use.
引用
收藏
页码:391 / 395
页数:5
相关论文
共 50 条
  • [1] Cardiovascular Effects of Drugs Used to Treat Alzheimer’s Disease
    Laurence Guy Howes
    Drug Safety, 2014, 37 : 391 - 395
  • [4] Cost of drugs used to treat cardiovascular disease in Brazil
    Bueno, Cristiane Schmalz
    Moreira, Angelica Cristiane
    de Oliveira, Karla Renata
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2012, 31 (01): : 62 - 67
  • [5] Inhibition of human cholinesterases by drugs used to treat Alzheimer disease
    Darvesh, S
    Walsh, R
    Kumar, R
    Caines, A
    Roberts, S
    Magee, D
    Rockwood, K
    Martin, E
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2003, 17 (02): : 117 - 126
  • [6] Unintended Effects of Cardiovascular Drugs on the Pathogenesis of Alzheimer's Disease
    Wang, Jun
    Zhao, Zhong
    Lin, Emi
    Zhao, Wei
    Qian, Xianjuan
    Freire, Daniel
    Bilski, Amanda E.
    Cheng, Alice
    Vempati, Prashant
    Ho, Lap
    Ono, Kenjiro
    Yamada, Masahito
    Pasinetti, Giulio M.
    PLOS ONE, 2013, 8 (06):
  • [7] Nanotechnology based delivery systems of drugs currently used to treat alzheimer’s disease
    Choubdar N.
    Avizheh S.
    Nanoscience and Nanotechnology - Asia, 2020, 10 (03): : 228 - 247
  • [8] Could antivirals be used to treat Alzheimer's disease?
    Itzhaki, Ruth F.
    Wozniak, Matthew A.
    FUTURE MICROBIOLOGY, 2012, 7 (03) : 307 - 309
  • [9] Drugs used in Alzheimer's disease and neuroplasticity
    Allain, H
    BentueFerrer, D
    Gandon, JM
    LeDoze, F
    Belliard, S
    CLINICAL THERAPEUTICS, 1997, 19 (01) : 4 - 15
  • [10] Evolution of drugs used to treat cardiovascular disease from 1981 to 2021
    Ravindran, Virada
    Towers, Kate
    Baker, Emma
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (12) : 4900 - 4901